ephrin-a5 and Carcinoma, Pancreatic Ductal

ephrin-a5 has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Doi, N; Esaki, M; Hiraoka, N; Ino, Y; Ishimoto, U; Iwasaki, T; Kishi, Y; Naito, C; Nakajima, K; Nara, S; Shimada, K; Shimasaki, M	1

Other Studies

1 other study(ies) available for ephrin-a5 and Carcinoma, Pancreatic Ductal

Article	Year
Neoadjuvant therapy alters the collagen architecture of pancreatic cancer tissue via Ephrin-A5. British journal of cancer, 2022, Volume: 126, Issue:4 Topics: Antineoplastic Agents; Cancer-Associated Fibroblasts; Carcinoma, Pancreatic Ductal; Cell Proliferation; Collagen; Ephrin-A5; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Neoadjuvant Therapy; Pancreatic Neoplasms; Primary Cell Culture; Retrospective Studies; Signal Transduction; Tumor Cells, Cultured; Tumor Microenvironment	2022

Article

Year

Neoadjuvant therapy alters the collagen architecture of pancreatic cancer tissue via Ephrin-A5.

British journal of cancer, 2022, Volume: 126, Issue:4

Topics: Antineoplastic Agents; Cancer-Associated Fibroblasts; Carcinoma, Pancreatic Ductal; Cell Proliferation; Collagen; Ephrin-A5; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Neoadjuvant Therapy; Pancreatic Neoplasms; Primary Cell Culture; Retrospective Studies; Signal Transduction; Tumor Cells, Cultured; Tumor Microenvironment

2022